Drug Discovery News (ddn) Announces Exclusive Interviews With Plaintiffs Behind Federal Stem Cell Research Case

ROCKY RIVER, Ohio--(BUSINESS WIRE)-- Drug Discovery News (ddn), a news organization covering issues, trends and product news in the pharmaceutical drug development and discovery industry, recently conducted exclusive interviews with the lead plaintiffs in the controversial Sherley v. Sebelius lawsuit challenging President Barack Obama’s order granting funding for embryonic stem cell research.

The plaintiffs, Dr. James L. Sherley, a biological engineer at Boston Biomedical Research Institute, and Dr. Theresa Deisher, research and development director at AVM Biotechnology LLC in Seattle, discuss why they believe adult stem cell research holds more scientific progress, but fewer ethical concerns, and why they believe Obama’s order has intensified competition for limited government dollars, making it more difficult for them to get funding for their own work.

“Human embryonic stem cell research … continues to be misrepresented by many of its proponents who misstate its potential for providing medical advances and present it as if there were no alternatives, when in fact both adult stem cell research and traditional disease research are not only effective alternatives, but better ones in many respects,” Sherley says in the interview.

Deisher also discusses how her faith informs her research approach: “My Christian faith calls me to focus on drugs and treatments that are affordable so that the greatest number of people will benefit,” she says. “My faith also calls me to respect the intrinsic dignity of human life in my work.”

The interviews, as well as in-depth coverage of the lawsuit, are available in the December 2010 issue of ddn. For more information, visit: www.drugdiscoverynews.com/stemcell.

Drug Discovery News (ddn) is a monthly print newspaper and digital international edition, bi-monthly e-newsletter, blog, 24-7 companion website and e-New Product Showcase focused on covering issues, trends and product news that impact decision makers in the pharmaceutical drug development and discovery industries. Founded in 2005, ddn is published by Old River Publications LLC, an innovative publishing company based in Rocky River, Ohio, just west of Cleveland. For more information, visit www.drugdiscoverynews.com.



CONTACT:

Drug Discovery News
Amy Swinderman, Chief Editor, 216-912-8165
[email protected]

KEYWORDS:   United States  North America  Massachusetts  Ohio  Washington

INDUSTRY KEYWORDS:   Stem Cells  Education  University  Health  Biotechnology  Public Policy/Government  Healthcare Reform  Courts  Pharmaceutical  Other Policy Issues  Public Policy  State/Local  White House/Federal Government  Blogging  Search Engine Marketing  Search Engine Optimization  Social Media  Professional Services  Legal  Communications  Advertising  Marketing  Research  Other Science  Publishing  Science  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.